Patents by Inventor Yunqing FENG

Yunqing FENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230134672
    Abstract: A ketorolaco derivative as shown in formula (I) has a better half-life and stability, has good pharmacokinetic properties, and has a higher stability in vitro; and as a preparation, the ketorolaco derivative can enhance efficacy and reduce toxicity. The present invention well improves the defects of frequent administration, gastrointestinal side effects, poor compliance and the like in traditional ketorolaco preparations.
    Type: Application
    Filed: December 23, 2022
    Publication date: May 4, 2023
    Inventors: Hai YE, Tao MIN, Tian LV, Wenliang ZHOU, Xingran CHEN, Yunqing FENG, Meiling MO, Jialin WANG
  • Publication number: 20230000812
    Abstract: Provided is an ibuprofen ester prodrug represented by Structural Formula (1), a racemate, stereoisomer or pharmaceutically acceptable salt or solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof. Further provided are a method for preparing the compound, a pharmaceutical composition containing the compound, and an application of the compound in preparation of nonsteroidal anti-inflammatory drugs. The pharmaceutical composition containing the ibuprofen ester prodrug may be prepared into fat emulsion injection preparations. The ibuprofen ester prodrug has good stability and good pharmacokinetic properties and overcomes the problems of ibuprofen such as a short half-life, poor stability, irritation, and incompatibility.
    Type: Application
    Filed: June 28, 2021
    Publication date: January 5, 2023
    Applicant: NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Hai YE, Tao MIN, Tian LV, Wenliang ZHOU, Xingran CHEN, Yunqing FENG, Meiling MO, Jialin WANG
  • Publication number: 20220274911
    Abstract: Provided are an arylpropionic acid derivative represented by Formula (I), a pharmaceutical composition and a preparation method and an application thereof. The arylpropionic acid derivative has a good half-life, pharmacokinetic property and in vitro stability and can enhance efficacy and reduce toxicity after formulated into preparations, which repairs the defects of frequent administration, gastrointestinal side effects and poor patient compliance of traditional nonsteroidal anti-inflammatory drugs.
    Type: Application
    Filed: September 8, 2021
    Publication date: September 1, 2022
    Applicant: NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Hai YE, Tao MIN, Tian LV, Wenliang ZHOU, Ying XU, Yunqing FENG